Wildcat Capital Management’s Editas Medicine EDIT Stock Holding History

Wildcat Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-185,668	Closed	-$4.59M	–	31
2019 Q2	$4.59M	Hold	185,668	–	–	1.99%	11
2019 Q1	$4.54M	Hold	185,668	–	–	2.66%	10
2018 Q4	$4.22M	Hold	185,668	–	–	2.78%	7
2018 Q3	$5.91M	Hold	185,668	–	–	4.56%	5
2018 Q2	$6.65M	Hold	185,668	–	–	5.09%	5
2018 Q1	$6.16M	Buy	+185,668	New	+$6.62M	5.08%	5
2017 Q4	–	Sell	-41,324	Closed	-$992K	–	13
2017 Q3	$992K	Hold	41,324	–	–	0.18%	14
2017 Q2	$693K	Hold	41,324	–	–	0.18%	17
2017 Q1	$922K	Hold	41,324	–	–	0.29%	13
2016 Q4	$671K	Sell	41,324 -5,451	-12%	-$82.7K	0.31%	11
2016 Q3	$631K	Sell	46,775 -13,025	-22%	-$267K	0.19%	23
2016 Q2	$1.46M	Sell	59,800 -187,968	-76%	-$6.34M	0.55%	13
2016 Q1	$8.56M	Buy	+247,768	New	+$6.51M	2.98%	7

Other funds holding EDIT

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wildcat Capital Management's EDIT Position: Q3 2019 in Review

Wildcat Capital Management sold out of Editas Medicine (EDIT) in Q3 2019, closing a stake of 185,668 shares — an estimated $4.59M sold.

Wildcat Capital Management first reported a position in EDIT in Q1 2016 and held it in 13 quarters. The position peaked at $8.56M in Q1 2016. 187 funds tracked by Wall St. Rank hold EDIT as of Q3 2019.

Wildcat Capital Management reported no remaining Editas Medicine position as of Q3 2019 after selling out during the quarter.
Wildcat Capital Management sold 185,668 Editas Medicine shares in Q3 2019, an estimated $4.59M.
Wildcat Capital Management first reported a position in Editas Medicine in Q1 2016 and held it in 13 quarters.
Wildcat Capital Management's Editas Medicine position peaked at $8.56M in Q1 2016.
187 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2019.

Based on Wildcat Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.